Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
10X Research's latest report: Is Bitcoin breaking through? Key events and market dynamics analysis

10X Research's latest report: Is Bitcoin breaking through? Key events and market dynamics analysis

远山洞见2024/07/29 06:26
According to a 10x Research report, bitcoin usually generates flat returns in August and decreases in September. Despite the downward pressure on the $1 billion token unlock in August, the US interest rate policy, lower inflation and election schedule may ease this pressure.
 
Bitcoin's rise requires the help of macroeconomic factors. The FOMC meeting on July 31st and the US CPI report on August 14th will be critical moments. Bitcoin's dominant position has increased to 55.5%, the highest since April 2021, and has been in a downward trend since March. If it breaks through 69,000, it may accelerate its rise. Bitcoin spot ETFs are gradually increasing, but the market structure is weak and stablecoin minting is low. Presidential candidate comments have limited impact on Bitcoin, but political support is a positive signal.
 
The report finally reminds us to pay attention to multiple major token unlocks and market trends, and lists them one by one.
 
For more information, see the latest research report from 10x Research: https://www.bitget.com/news/detail/12560604123835
 
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)

A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.

智通财经2026/08/29 02:27
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)